Messia Nazar, Jenny E Kootstra-Ros, Paola Mian, Daniel J Touw, Marieke G G Sturkenboom
{"title":"乙酰半胱氨酸对凝血酶原时间及国际标准化比值的影响。","authors":"Messia Nazar, Jenny E Kootstra-Ros, Paola Mian, Daniel J Touw, Marieke G G Sturkenboom","doi":"10.1080/15563650.2025.2451642","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Patients poisoned with paracetamol are treated with acetylcysteine. In patients without hepatocellular injury, an increased prothrombin time or international normalized ratio has been observed during acetylcysteine administration. The international normalized ratio is preferred as it is a standardized calculation of prothrombin time independent of reagents and machinery. Since the prothrombin time and international normalized ratio are used as markers of liver injury in patients with paracetamol poisoning, it is important to assess the magnitude of the effect of acetylcysteine treatment on the prothrombin time and international normalized ratio. The aim of this narrative review is to describe the effect of acetylcysteine on the prothrombin time and international normalized ratio.</p><p><strong>Methods: </strong>Embase, PubMed and Web of Science were searched to identify the effect of acetylcysteine on coagulation factors II, VII, IX or X, the prothrombin time and the international normalized ratio in <i>in vitro</i> and <i>in vivo</i> studies in healthy subjects and clinical studies involving both those poisoned with paracetamol and surgical patients. The search terms employed were acetylcysteine combined with prothrombin time, international normalized ratio, coagulation or haemostasis.</p><p><strong>Results: </strong>The search identified a total of 2,471 articles, of which 19 studies were included. Six <i>in vitro</i> and/or <i>in vivo</i> studies, five clinical studies in paracetamol-poisoned patients and eight clinical studies in surgical patients were included. Acetylcysteine caused a 15-30% increase in prothrombin time and international normalized ratio. This increase was dose-dependent and was caused by a decrease in the activity of coagulation factors II, VII, IX and X. The effect of acetylcysteine on the increased prothrombin time and international normalized ratio was more prominent after the high loading dose but remained present during the lower maintenance dose of acetylcysteine. The effect was observed in both <i>in vitro</i> and <i>in vivo</i> studies and confirmed in clinical studies in paracetamol-poisoned patients without hepatic injury. Studies in surgical patients treated with acetylcysteine showed conflicting results. Twelve of the 13 clinical studies suffered from risk of bias, limiting the value of these studies.</p><p><strong>Discussion: </strong>The moderate 15-30% increase in the international normalized ratio induced by acetylcysteine is especially important in hospitals using the international normalized ratio as a marker for hepatotoxicity due to paracetamol poisoning and underlines the need for the international normalized ratio to be assessed at admission.</p><p><strong>Conclusion: </strong>Acetylcysteine treatment leads to an estimated 15-30% increase in prothrombin time and international normalized ratio in both experimental studies and paracetamol-poisoned patients. Isolated increases in prothrombin time and international normalized ratio during acetylcysteine infusion are common and do not necessarily reflect liver dysfunction or liver injury.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"166-175"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review.\",\"authors\":\"Messia Nazar, Jenny E Kootstra-Ros, Paola Mian, Daniel J Touw, Marieke G G Sturkenboom\",\"doi\":\"10.1080/15563650.2025.2451642\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Patients poisoned with paracetamol are treated with acetylcysteine. In patients without hepatocellular injury, an increased prothrombin time or international normalized ratio has been observed during acetylcysteine administration. The international normalized ratio is preferred as it is a standardized calculation of prothrombin time independent of reagents and machinery. Since the prothrombin time and international normalized ratio are used as markers of liver injury in patients with paracetamol poisoning, it is important to assess the magnitude of the effect of acetylcysteine treatment on the prothrombin time and international normalized ratio. The aim of this narrative review is to describe the effect of acetylcysteine on the prothrombin time and international normalized ratio.</p><p><strong>Methods: </strong>Embase, PubMed and Web of Science were searched to identify the effect of acetylcysteine on coagulation factors II, VII, IX or X, the prothrombin time and the international normalized ratio in <i>in vitro</i> and <i>in vivo</i> studies in healthy subjects and clinical studies involving both those poisoned with paracetamol and surgical patients. The search terms employed were acetylcysteine combined with prothrombin time, international normalized ratio, coagulation or haemostasis.</p><p><strong>Results: </strong>The search identified a total of 2,471 articles, of which 19 studies were included. Six <i>in vitro</i> and/or <i>in vivo</i> studies, five clinical studies in paracetamol-poisoned patients and eight clinical studies in surgical patients were included. Acetylcysteine caused a 15-30% increase in prothrombin time and international normalized ratio. This increase was dose-dependent and was caused by a decrease in the activity of coagulation factors II, VII, IX and X. The effect of acetylcysteine on the increased prothrombin time and international normalized ratio was more prominent after the high loading dose but remained present during the lower maintenance dose of acetylcysteine. The effect was observed in both <i>in vitro</i> and <i>in vivo</i> studies and confirmed in clinical studies in paracetamol-poisoned patients without hepatic injury. Studies in surgical patients treated with acetylcysteine showed conflicting results. Twelve of the 13 clinical studies suffered from risk of bias, limiting the value of these studies.</p><p><strong>Discussion: </strong>The moderate 15-30% increase in the international normalized ratio induced by acetylcysteine is especially important in hospitals using the international normalized ratio as a marker for hepatotoxicity due to paracetamol poisoning and underlines the need for the international normalized ratio to be assessed at admission.</p><p><strong>Conclusion: </strong>Acetylcysteine treatment leads to an estimated 15-30% increase in prothrombin time and international normalized ratio in both experimental studies and paracetamol-poisoned patients. Isolated increases in prothrombin time and international normalized ratio during acetylcysteine infusion are common and do not necessarily reflect liver dysfunction or liver injury.</p>\",\"PeriodicalId\":10430,\"journal\":{\"name\":\"Clinical Toxicology\",\"volume\":\" \",\"pages\":\"166-175\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15563650.2025.2451642\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15563650.2025.2451642","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
对乙酰氨基酚中毒的病人用乙酰半胱氨酸治疗。在没有肝细胞损伤的患者中,观察到乙酰半胱氨酸给药期间凝血酶原时间或国际标准化比率增加。首选国际标准化比率,因为它是独立于试剂和机械的凝血酶原时间的标准化计算。由于凝血酶原时间和国际标准化比率是对乙酰氨基酚中毒患者肝损伤的标志物,因此评估乙酰半胱氨酸治疗对凝血酶原时间和国际标准化比率的影响程度是很重要的。本文的目的是描述乙酰半胱氨酸对凝血酶原时间和国际标准化比值的影响。方法:检索Embase、PubMed和Web of Science,通过健康受试者的体内体外研究以及扑热息痛中毒患者和外科患者的临床研究,确定乙酰半胱氨酸对凝血因子II、VII、IX或X、凝血酶原时间和国际标准化比值的影响。搜索词为:乙酰半胱氨酸联合凝血酶原时间、国际标准化比值、凝血或止血。结果:检索共确定了2471篇文章,其中包括19项研究。包括6项体外和/或体内研究,5项对扑热息痛中毒患者的临床研究和8项手术患者的临床研究。乙酰半胱氨酸使凝血酶原时间和国际标准化比值增加15-30%。这种增加是剂量依赖性的,是由凝血因子II、VII、IX和x的活性降低引起的。乙酰半胱氨酸对凝血酶原时间的增加和国际标准化比率的影响在高负荷剂量后更为突出,但在乙酰半胱氨酸维持剂量较低时仍然存在。对乙酰氨基酚中毒无肝损伤患者的体外和体内研究证实了这种作用。对用乙酰半胱氨酸治疗的外科病人的研究显示了相互矛盾的结果。13项临床研究中有12项存在偏倚风险,限制了这些研究的价值。讨论:乙酰半胱氨酸引起的国际标准化比率中度升高15-30%在医院使用国际标准化比率作为扑热息痛中毒肝毒性的标志时尤为重要,并强调了在入院时评估国际标准化比率的必要性。结论:在实验研究和扑热息痛中毒患者中,乙酰半胱氨酸治疗可导致凝血酶原时间和国际标准化比率增加约15-30%。在乙酰半胱氨酸输注过程中,凝血酶原时间和国际标准化比值的单独增加是常见的,并不一定反映肝功能障碍或肝损伤。
The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review.
Introduction: Patients poisoned with paracetamol are treated with acetylcysteine. In patients without hepatocellular injury, an increased prothrombin time or international normalized ratio has been observed during acetylcysteine administration. The international normalized ratio is preferred as it is a standardized calculation of prothrombin time independent of reagents and machinery. Since the prothrombin time and international normalized ratio are used as markers of liver injury in patients with paracetamol poisoning, it is important to assess the magnitude of the effect of acetylcysteine treatment on the prothrombin time and international normalized ratio. The aim of this narrative review is to describe the effect of acetylcysteine on the prothrombin time and international normalized ratio.
Methods: Embase, PubMed and Web of Science were searched to identify the effect of acetylcysteine on coagulation factors II, VII, IX or X, the prothrombin time and the international normalized ratio in in vitro and in vivo studies in healthy subjects and clinical studies involving both those poisoned with paracetamol and surgical patients. The search terms employed were acetylcysteine combined with prothrombin time, international normalized ratio, coagulation or haemostasis.
Results: The search identified a total of 2,471 articles, of which 19 studies were included. Six in vitro and/or in vivo studies, five clinical studies in paracetamol-poisoned patients and eight clinical studies in surgical patients were included. Acetylcysteine caused a 15-30% increase in prothrombin time and international normalized ratio. This increase was dose-dependent and was caused by a decrease in the activity of coagulation factors II, VII, IX and X. The effect of acetylcysteine on the increased prothrombin time and international normalized ratio was more prominent after the high loading dose but remained present during the lower maintenance dose of acetylcysteine. The effect was observed in both in vitro and in vivo studies and confirmed in clinical studies in paracetamol-poisoned patients without hepatic injury. Studies in surgical patients treated with acetylcysteine showed conflicting results. Twelve of the 13 clinical studies suffered from risk of bias, limiting the value of these studies.
Discussion: The moderate 15-30% increase in the international normalized ratio induced by acetylcysteine is especially important in hospitals using the international normalized ratio as a marker for hepatotoxicity due to paracetamol poisoning and underlines the need for the international normalized ratio to be assessed at admission.
Conclusion: Acetylcysteine treatment leads to an estimated 15-30% increase in prothrombin time and international normalized ratio in both experimental studies and paracetamol-poisoned patients. Isolated increases in prothrombin time and international normalized ratio during acetylcysteine infusion are common and do not necessarily reflect liver dysfunction or liver injury.
期刊介绍:
clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology, the European Association of Poisons Centres and Clinical Toxicologists, the American Association of Poison Control Centers and the Asia Pacific Association of Medical Toxicology and, as such, is the leading international journal in the specialty.